Impact Report: Colossal Sets New Goal After Raising Over $9.6M in 2022
Favorite Chef, Skatepark Hero, and Super Mom to run this year
Colossal Management A global leader in modern giving.
…
The post Impact Report: Colossal Sets New Goal After Raising Over $9.6M in 2022 first appeared on RSVTV news.
ZEUS Scientific Introduces the SP30 IFA Slide Processor for dIFine as Part of the dIFine 30 System
dIFine 30 system is ZEUS Scientific’s complete solution for IFA slide processing and digital immunofluorescence imaging
![ZEUS Scientific Introduces the SP30 IFA Slide Processor for dIFine as Part of the dIFine 30 System ZEUS Scientific Introduces the SP30 IFA Slide Processor for dIFine as Part of the dIFine 30 System](https://cdn.newswire.com/files/x/a0/3b/134471ab211d258cf7a48a55645c.jpg)
dIFine 30 System
A complete system for IFA slide processing and digital immunofluorescence imaging – including cover slipping!
BRANCHBURG, N.J., March 17, 2023 (Newswire.com)
–
Today, ZEUS Scientific launched the dIFine 30 System, a powerful partnership pairing the ZEUS dIFine® digital immunofluorescence system with the new ZEUS SP30 slide processor. The SP30 is an easy-to-use and efficient walk-away benchtop instrument for IFA slide processing, designed to improve laboratory workflow and ensure high-quality results, including cover slipping. The SP30 can process up to 240 samples on 30 ZEUS IFA slides. With its three-probe system for fast, accurate pipetting and slide well washing, it precisely dispenses mounting media and adds coverslips, decreasing slide handling and the risk of artifacts/bubbles. The multi-drop individual well-to-well washing eliminates the risk of carryover or cross-contamination. ZEUS ANA IFA test kits feature ready-to-use reagents that can be directly loaded onto the SP30 – no pour off. Its user-friendly, intuitive software works with ZEUS dIFine, allowing for parallel processing and scanning sessions. The system connects to laboratories’ LIS to receive test requests and share the worklist with dIFine, boosting efficiency.
The FDA-cleared ZEUS dIFine System is the next generation in IFA imaging, interpretation, and pattern recognition, designed to acquire, analyze, display and store digital images of ZEUS IFA HEp-2 cells. An automated digital scanner with intelligent software, dIFine quickly delivers positive/negative results and is FDA-cleared to suggest eight common ANA HEp-2 patterns (homogenous, speckled, centromere, nucleolar, nuclear dots, nuclear membrane, cytoplasmic (ribosomal and mitochondrial)).* dIFine also instantly locates and identifies mitotic cells, assisting in pattern identification. The ability to quickly view/validate all negative samples saves users valuable time. The built-in pattern atlas can be used as a reference or training tool, allowing side-by-side comparison with ZEUS proprietary images aligned with ICAP nomenclature.
ANA HEp-2 IFA is the American College of Rheumatology (ACR) gold standard for ANA testing. A pioneer in IFA technology, ZEUS has continually delivered quality products and expertise in autoimmune serology that laboratories have relied upon since 1976.
For 45+ years, laboratories have trusted ZEUS Scientific to provide high-quality IFA ANA HEp-2 products. The ZEUS proprietary cell fixation process allows technologists to work with cells containing natural, unaltered antigens and provides clear, crisp images; excellent cell morphology; and a high number of mitotic cells, all which make pattern determination easier.
With this new launch, laboratories can take their ANA IFA testing to the next level by pairing ZEUS’s top-tier IFA ANA HEp-2 slides with the ZEUS dIFine 30 System. In addition, ZEUS is in the final phases of FDA submission for dIFine automated negative/positive determination and detection of anti-dsDNA (nDNA/Crithidia) antibodies in 2023.
For more information, please visit the ZEUS website or contact the ZEUS sales team.
* FDA 510(k) cleared. All suggested results obtained with ZEUS dIFine must be confirmed by a trained operator.
Contact Information:
Travis Smyre
Vice President Commercial
908-243-4911
Original Source:
ZEUS Scientific Introduces the SP30 IFA Slide Processor for dIFine as Part of the dIFine 30 System
ZEUS Scientific Introduces the SP30 IFA Slide Processor for dIFine as Part of the dIFine 30 System
dIFine 30 system is ZEUS Scientific’s complete solution for IFA slide processing and digital immunofluorescence imaging
![ZEUS Scientific Introduces the SP30 IFA Slide Processor for dIFine as Part of the dIFine 30 System ZEUS Scientific Introduces the SP30 IFA Slide Processor for dIFine as Part of the dIFine 30 System](https://cdn.newswire.com/files/x/a0/3b/134471ab211d258cf7a48a55645c.jpg)
dIFine 30 System
A complete system for IFA slide processing and digital immunofluorescence imaging – including cover slipping!
BRANCHBURG, N.J., March 17, 2023 (Newswire.com)
–
Today, ZEUS Scientific launched the dIFine 30 System, a powerful partnership pairing the ZEUS dIFine® digital immunofluorescence system with the new ZEUS SP30 slide processor. The SP30 is an easy-to-use and efficient walk-away benchtop instrument for IFA slide processing, designed to improve laboratory workflow and ensure high-quality results, including cover slipping. The SP30 can process up to 240 samples on 30 ZEUS IFA slides. With its three-probe system for fast, accurate pipetting and slide well washing, it precisely dispenses mounting media and adds coverslips, decreasing slide handling and the risk of artifacts/bubbles. The multi-drop individual well-to-well washing eliminates the risk of carryover or cross-contamination. ZEUS ANA IFA test kits feature ready-to-use reagents that can be directly loaded onto the SP30 – no pour off. Its user-friendly, intuitive software works with ZEUS dIFine, allowing for parallel processing and scanning sessions. The system connects to laboratories’ LIS to receive test requests and share the worklist with dIFine, boosting efficiency.
The FDA-cleared ZEUS dIFine System is the next generation in IFA imaging, interpretation, and pattern recognition, designed to acquire, analyze, display and store digital images of ZEUS IFA HEp-2 cells. An automated digital scanner with intelligent software, dIFine quickly delivers positive/negative results and is FDA-cleared to suggest eight common ANA HEp-2 patterns (homogenous, speckled, centromere, nucleolar, nuclear dots, nuclear membrane, cytoplasmic (ribosomal and mitochondrial)).* dIFine also instantly locates and identifies mitotic cells, assisting in pattern identification. The ability to quickly view/validate all negative samples saves users valuable time. The built-in pattern atlas can be used as a reference or training tool, allowing side-by-side comparison with ZEUS proprietary images aligned with ICAP nomenclature.
ANA HEp-2 IFA is the American College of Rheumatology (ACR) gold standard for ANA testing. A pioneer in IFA technology, ZEUS has continually delivered quality products and expertise in autoimmune serology that laboratories have relied upon since 1976.
For 45+ years, laboratories have trusted ZEUS Scientific to provide high-quality IFA ANA HEp-2 products. The ZEUS proprietary cell fixation process allows technologists to work with cells containing natural, unaltered antigens and provides clear, crisp images; excellent cell morphology; and a high number of mitotic cells, all which make pattern determination easier.
With this new launch, laboratories can take their ANA IFA testing to the next level by pairing ZEUS’s top-tier IFA ANA HEp-2 slides with the ZEUS dIFine 30 System. In addition, ZEUS is in the final phases of FDA submission for dIFine automated negative/positive determination and detection of anti-dsDNA (nDNA/Crithidia) antibodies in 2023.
For more information, please visit the ZEUS website or contact the ZEUS sales team.
* FDA 510(k) cleared. All suggested results obtained with ZEUS dIFine must be confirmed by a trained operator.
Contact Information:
Travis Smyre
Vice President Commercial
908-243-4911
Original Source:
ZEUS Scientific Introduces the SP30 IFA Slide Processor for dIFine as Part of the dIFine 30 System